Production of cachexia mediators by Walker 256 cells from ascitic tumors

Cell Biochemistry and Function

Volumn 26, Issue 6, 2008, Pages 731-738

  Rebeca, Rosilene ^a,b   Bracht, Lívia ^a   Noleto, Guilhermina Rodrigues ^a   Martinez, Glaucia Regina ^a   Cadena, Silvia Maria Suter Correia ^a   Carnieri, Eva Gunilla Skare ^a   Rocha, Maria Eliane Merlin ^a   de Oliveira, Maria Benigna Martinelli ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSIDADE ESTADUAL DO CENTRO OESTE   (Brazil)

Author keywords

Arginase; Cachexia; IL 6; NOS; PGE2; Polyamines; TNF ; Walker 256 tumor

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE; POLYAMINE; PROSTAGLANDIN E2; PUTRESCINE; SPERMIDINE; SPERMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES TUMOR; CACHEXIA; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; IN VITRO STUDY; MALE; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; WALKER CARCINOMA;

ANIMALS; ARGINASE; ASCITIC FLUID; BIOGENIC POLYAMINES; CACHEXIA; CARCINOMA 256, WALKER; CELL LINE, TUMOR; DINOPROSTONE; INTERLEUKIN-6; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; UREA;

EID: 52649117146     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1497     Document Type: Article

References (40)

1. Tisdale MJ. Cancer cachexia: metabolic alteration and clinical manifestation. Nutrition 1997; 13: 1-7.
2. Kotlet DP. Cachexia. Ann Intern Med 2000: 133: 622-634.
3. Mantovani A, Bottazzi B, Sozzani S. et al. Cytokine regulation of tumour-associated macrophages. Res Immunol 1993; 144: 280-308.
4. Argilés JM, Busquets S. García-Martínez C. López-Soriano FJ. Mediators involved in the cancer anorexia-cachexia syndrome: past. present and future. Nutrition 2005; 21: 977-985.
5. Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 2006; 16: 38-52.
6. Perroud APAS. Achimine R. Monteiro de Castro G, et al. Cytokine gene expression in Walker 256: a comparison of variants A (agressive) and AR (regressive). Cytokine 2006; 36: 123-133.
7. McNamara JM, Richard Alexander H, Norton JA. Cytokines and their role in the pathophysiology of cancer cachexia. J Parent Ent Nutr 1992; 16: 50-55.
8. Zaletok S, Alexandrova N, Berdynskykh N, et al. Role of polyamines in the function of nuclear transcription factor NF-κB in breast cancer cells. Exp Oncol 2004; 26: 221-225.
9. Kuriyan I. Thamos D. Structure of NF-κB transcriptor factor: a holistic interaction with DNA. Structure 1995; 3: 135-141.
10. Aggarwal BB, Shishodia S. Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006; 72: 1605-1621.
11. Gallo O, Fabbroni V, Sardi I. Magnelli L, Bodch V, Franchi A. Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous carcinomas. Biochem Biophys Res Comun 2002; 299: 517-524.
12. Xing Z. Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldic TJ. Cytokine expression by neutrophils and macrophages in vitro: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not rantes or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 1994; 10: 148-153.
13. Ishii Y, Yang H, Sakamoto T, et al. Rat alveolar macrophage cytokine production and regulation of neutrophil recruitment following acute ozone exposure. Toxicol Appl Pharmacol 1997; 147: 214-223.
14. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005: 310: 1504-1510.
15. Strelkov AB, Fields ALA, Baracos VE. Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. Cell Physiol 1989; 257: C261-C269.
16. 2 reduction associated with apoptosis and increased peroxidation. Prost Leuk Essen Fat Acids 2007; 76: 113-120.
17. Vicentino C, Constantin J, Bracht A, Yamamoto NS, Long-chain fatty acid uptake and oxidation in the perfused liver of Walker-256 tumour-bearing rats. Liver 2002; 22: 341-349.
18. Corbello Pereira SR, Darronqui E, Constantin J, da Silva MH, Yamamoto NS, Bracht A. The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats. Biochim Biophys Acta 2004; 1688: 187-196.
19. Moloktov A. Satoh M, Tohyama C. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Lett 1998; 132: 187-192.
20. Wu G, Morris M. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.
21. Tapiero H, Mathé G, Couvreur P, Tew KD. Dossier: free amino acids in human health and pathologies, I. Arginine. Biomed Pharmacother 2002; 56: 439-445.
22. Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids 2004; 26: 321-329.
23. Phillips HJ. Dye exclusions tests for cell viability. In Tissue culture, methods and applications, Kruse JR, Patterson JRMK (eds). Academic Press: New York, 1973; 406-408.
24. 15N]nitrate in biological fluids. Anal Biochem 1992: 126: 131-138.
25. Shimke TT. Adaptative characteristics of urea cycle enzymes in the rat. J Biol Chem 1962; 237: 459-468.
26. Bach SJ, Killip JD. Studies on tile purification and the kinetic properties of arginase from beef, sheep ad horse liver. Biochim Biophys Acta 1961; 47: 336-343.
27. Satoh PS, Ito Y. Quantitative rapid microassay of arginase. Anal Biochem 1968; 23: 219-229.
28. Shenkel E, Berlaimont V, Dubois J, Helson-Cambier M, Hanocq M. Improved high-performance liquid chromatographic method for the determination of polyamines as their benzoylated derivatives: application to P388 cells. J Chrom B 1995: 668: 189-197.
29. Edwards P, Cendan JC, Topping DB, et al. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 1996: 63: 49-52.
30. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 1999: 81: 889-896.
31. Guaitani A, Recchia M, Carli M, Rochetti M, Bartosek I, Garattini S. Walker carcinoma 256: a model for studies on tumor-induced anorexia and cachexia. Oncology 1982; 39: 173-178.
32. Wheatley DN. Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumor cells. Semin Cancer Biol 2005; 15: 247-253.
33. Bjelakovic G, Pavlovic D, Stojanovic I, Jevtovic T, Nikolic J, Kocic G. Effects of glucocorticoids on polyamine metabolism in liver and spleen of guinea pig during sensitization. Amino Acids 2006; 4: 457-462.
34. Williams-Ashman HG, Coppoc GL, Weber G. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine, and spermine. Cancer Res 1972; 32: 1924-1932.
35. ω-Hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 2000; 60: 3305-3312.
36. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumor progression. Lancet Oncol 2001; 3: 149-156.
37. Waki Y, Nomura M, Kasugai S, Ohya K, Miyamoto K. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone. Cancer Res 1999; 59: 1219-1224.
38. Costelli P, Carbo N, Tessitore L, et al. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993; 92: 2783-2789.
39. Brigatte P, Sampaio SC, Gutierrez VP, et al. Walker 256 tumor-bearing rats as a model to study cancer pain. J Pain 2007; 8: 412-421.
40. Barton BE. Interteukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes. Expert Opin Ther Targets 2005; 9: 737-752. DOI:10.1517/14728222.9.4.737